Published in Invest Ophthalmol Vis Sci on March 01, 2017
Optical coherence tomography. Science (1991) 57.87
Optical coherence tomography of the human retina. Arch Ophthalmol (1995) 8.90
Gene therapy restores vision in a canine model of childhood blindness. Nat Genet (2001) 7.88
In vivo retinal imaging by optical coherence tomography. Opt Lett (1993) 5.18
Perspective on genes and mutations causing retinitis pigmentosa. Arch Ophthalmol (2007) 4.27
Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat Genet (2000) 3.72
Inherited retinal dystrophy: primary defect in pigment epithelium determined with experimental rat chimeras. Science (1976) 2.59
Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells (2009) 2.56
Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One (2009) 2.54
Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis. Mol Ther (2005) 2.27
Spectral domain optical coherence tomography in mouse models of retinal degeneration. Invest Ophthalmol Vis Sci (2009) 2.08
Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk. Proc Natl Acad Sci U S A (2001) 1.91
In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous. Sci Transl Med (2013) 1.86
Influence of eye pigmentation and light deprivation on inherited retinal dystrophy in the rat. Exp Eye Res (1975) 1.77
Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa. Mol Ther (2010) 1.75
Assessment of artifacts and reproducibility across spectral- and time-domain optical coherence tomography devices. Ophthalmology (2009) 1.42
In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol (2012) 1.36
Long-term characterization of retinal degeneration in rd1 and rd10 mice using spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci (2012) 1.27
Long-term rescue of retinal structure and function by rhodopsin RNA replacement with a single adeno-associated viral vector in P23H RHO transgenic mice. Hum Gene Ther (2012) 1.24
Inherited retinal dystrophy in the RCS rat: prevention of photoreceptor degeneration by pigment epithelial cell transplantation. Exp Eye Res (1988) 1.21
Ganglion cell loss in RCS rat retina: a result of compression of axons by contracting intraretinal vessels linked to the pigment epithelium. J Comp Neurol (1998) 1.17
Role of the pigment epithelium in inherited retinal degeneration analyzed with experimental mouse chimeras. Exp Eye Res (1976) 1.13
A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Res (2012) 1.10
Quantification of spatial vision in the Royal College of Surgeons rat. Invest Ophthalmol Vis Sci (2004) 1.07
Spatial correlation of mouse photoreceptor-RPE thickness between SD-OCT and histology. Exp Eye Res (2010) 1.07
Syngeneic Schwann cell transplantation preserves vision in RCS rat without immunosuppression. Invest Ophthalmol Vis Sci (2007) 1.05
Morphological changes in the Royal College of Surgeons rat retina during photoreceptor degeneration and after cell-based therapy. J Comp Neurol (2005) 1.03
Legacy of the RCS rat: impact of a seminal study on retinal cell biology and retinal degenerative diseases. Prog Brain Res (2001) 1.01
Transplantation of human central nervous system stem cells - neuroprotection in retinal degeneration. Eur J Neurosci (2012) 0.99
Tyrosine-mutant AAV8 delivery of human MERTK provides long-term retinal preservation in RCS rats. Invest Ophthalmol Vis Sci (2012) 0.98
Photoreceptor characteristics in congenic strains of RCS rats. Invest Ophthalmol Vis Sci (1981) 0.97
Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa. Hum Gene Ther Clin Dev (2013) 0.96
Retinal Ganglion Cell Loss and Mild Vasculopathy in Methylene Tetrahydrofolate Reductase (Mthfr)-Deficient Mice: A Model of Mild Hyperhomocysteinemia. Invest Ophthalmol Vis Sci (2015) 0.95
Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial. Hum Genet (2016) 0.94
Clinical characteristics and current therapies for inherited retinal degenerations. Cold Spring Harb Perspect Med (2014) 0.92
Discordant anatomical, electrophysiological, and visual behavioral profiles of retinal degeneration in rat models of retinal degenerative disease. Invest Ophthalmol Vis Sci (2012) 0.90
AAV-mediated lysophosphatidylcholine acyltransferase 1 (Lpcat1) gene replacement therapy rescues retinal degeneration in rd11 mice. Invest Ophthalmol Vis Sci (2014) 0.89
Assessment of possible transneuronal changes in the retina of rats with inherited retinal dystrophy: cell size, number, synapses, and axonal transport by retinal ganglion cells. J Comp Neurol (1984) 0.88
Comparative analysis of repeatability of manual and automated choroidal thickness measurements in nonneovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2013) 0.88
Retinal pigment epithelial cell transplantation in RCS rats: normal metabolism in rescued photoreceptors. Exp Eye Res (1992) 0.87
No age-related cell loss in three retinal nuclear layers of the Long-Evans rat. Vis Neurosci (2007) 0.86
Photoreceptor degeneration in the RCS rat attenuates dendritic transport and axonal regeneration of ganglion cells. Invest Ophthalmol Vis Sci (2000) 0.86
Inherited retinal dystrophy in the RCS rat: composition of the outer segment debris zone. Prog Clin Biol Res (1989) 0.83
High resolution imaging of fluorescein patterns in RCS rat retinae and their direct correlation with histology. Exp Eye Res (2005) 0.82
Correlation between SD-OCT, immunocytochemistry and functional findings in an animal model of retinal degeneration. Front Neuroanat (2014) 0.82
Real-Time Automatic Segmentation of Optical Coherence Tomography Volume Data of the Macular Region. PLoS One (2015) 0.82
Phagocytosis of photoreceptor outer segments by transplanted human neural stem cells as a neuroprotective mechanism in retinal degeneration. Invest Ophthalmol Vis Sci (2013) 0.81
Survival and Functionality of hESC-Derived Retinal Pigment Epithelium Cells Cultured as a Monolayer on Polymer Substrates Transplanted in RCS Rats. Invest Ophthalmol Vis Sci (2016) 0.81
Ultrathin Polyimide Membrane as Cell Carrier for Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epithelium. PLoS One (2015) 0.79
Visual field loss in RCS rats and the effect of RPE cell transplantation. Exp Neurol (1998) 0.79
Gene Therapy for MERTK-Associated Retinal Degenerations. Adv Exp Med Biol (2016) 0.78
Comparison of Two Different OCT Systems: Retina Layer Segmentation and Impact on Structure-Function Analysis in Glaucoma. J Ophthalmol (2016) 0.78
AGE-RELATED MACULAR DEGENERATION. Rom J Ophthalmol (2016) 0.77
Development of a congenic strain of pigmented and albino rats for light damage studies. Exp Eye Res (1986) 0.77
Comparative study of human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSC) as a treatment for retinal dystrophies. Mol Ther Methods Clin Dev (2016) 0.77
Quantitative analysis of retinal OCT. Med Image Anal (2016) 0.76
Assessing Photoreceptor Structure in Retinitis Pigmentosa and Usher Syndrome. Invest Ophthalmol Vis Sci (2016) 0.83
Residual Foveal Cone Structure in CNGB3-Associated Achromatopsia. Invest Ophthalmol Vis Sci (2016) 0.78
Sarpogrelate, a 5-HT2A Receptor Antagonist, Protects the Retina From Light-Induced Retinopathy. Invest Ophthalmol Vis Sci (2015) 0.77
Specific Alleles of CLN7/MFSD8, a Protein That Localizes to Photoreceptor Synaptic Terminals, Cause a Spectrum of Nonsyndromic Retinal Dystrophy. Invest Ophthalmol Vis Sci (2017) 0.75